Data / Form D filings / QUINCY DRUG DEVELOPMENT, LLC
QUINCY DRUG DEVELOPMENT, LLC: Form D filing
QUINCY DRUG DEVELOPMENT, LLC, a biotechnology company in Madison, WI, filed a Form D with the SEC in 2011. The latest, on December 9, 2011, reports $7,150 sold of a $170,000 offering to 17 investors.
Find out what QUINCY DRUG DEVELOPMENT, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 301 SOUTH WESTFIELD ROAD, SUITE 200, Madison, WI, 53717
- Phone
- (608) 827-8000
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Wisconsin
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1536864
The full lists. Form D filings in Wisconsin: 361 rows, $18.05, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 9, 2011 | New notice | $170,000 | $7,150 | $162,850 | 17 | Dec 5, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Y. Underwood | Executive Officer | |
| Michael J. Beaman | Executive Officer |
Every Form D from the week of Dec 5, 2011 · All recent filings in Wisconsin · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what QUINCY DRUG DEVELOPMENT, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.